Core Laboratories
In AKO Capital's portfolio · London
Ticker CLB
Not in the portfolio as of Q3 2026. Every quarter it shows up in a London 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2021 | Sell | 0 | |
| Q2 2021 | Add 34% | 1,365,005 | 0.6% |
| Q1 2021 | Reduce 35% | 1,017,208 | 0.4% |
| Q4 2020 | Add 6% | 1,566,086 | 0.5% |
| Q3 2020 | Add 11% | 1,470,753 | 0.4% |
| Q2 2020 | Buy | 1,329,300 | 0.5% |
| Q3 2017 | Sell | 0 | |
| Q2 2017 | Add 3% | 310,226 | 2.8% |
| Q1 2017 | Add 16% | 301,562 | 3.1% |
| Q4 2016 | First 13F | 259,943 | 4.0% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.